Fragile X syndrome

Protecting against memory loss in Alzheimer’s disease with a Phase 2 clinical trial drug

The drug is now in Phase 2 clinical trials in patients with Alzheimer’s and Fragile

Fragile X syndrome is reversible at the neuron level in animal models

Fragile X syndrome is the most frequent cause of intellectual disability in males, affecting 1